NCT03351335View on ClinicalTrials.gov

Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 10, 2017

Primary Completion Date

August 9, 2018

Study Completion Date

August 9, 2018

Conditions
Mild to Moderate Skin Laxity Under the ChinMild to Moderate Skin Laxity on Neck
Interventions
DEVICE

Microfocused ultrasound with visualization

All subjects will receive an Ultherapy® treatment at dual depth using the 4-4.5mm and 7-3.0mm transducers. Treatments will be provided to the lower face, submental (under the chin) and neck area.

Trial Locations (7)

75093

Merz Investigational Site # 0010125, Plano

77056

Merz Investigational Site # 0010423, Houston

77401

Merz Investigational Site # 0010422, Bellaire

78745

Merz Investigational Site # 0010410, Austin

92083

Merz Investigational Site # 0010358, Vista

92121

Merz Investigational Site # 0010321, San Diego

95032

Merz Investigational Site # 0010411, Los Gatos

All Listed Sponsors
collaborator

Ulthera, Inc

INDUSTRY

lead

Merz North America, Inc.

INDUSTRY

NCT03351335 - Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients | Biotech Hunter | Biotech Hunter